Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Neurobiol Dis ; 168: 105702, 2022 06 15.
Article in English | MEDLINE | ID: mdl-35339680

ABSTRACT

Human doublecortin (DCX) mutations are associated with severe brain malformations leading to aberrant neuron positioning (heterotopia), intellectual disability and epilepsy. DCX is a microtubule-associated protein which plays a key role during neurodevelopment in neuronal migration and differentiation. Dcx knockout (KO) mice show disorganized hippocampal pyramidal neurons. The CA2/CA3 pyramidal cell layer is present as two abnormal layers and disorganized CA3 KO pyramidal neurons are also more excitable than wild-type (WT) cells. To further identify abnormalities, we characterized Dcx KO hippocampal neurons at subcellular, molecular and ultrastructural levels. Severe defects were observed in mitochondria, affecting number and distribution. Also, the Golgi apparatus was visibly abnormal, increased in volume and abnormally organized. Transcriptome analyses from laser microdissected hippocampal tissue at postnatal day 60 (P60) highlighted organelle abnormalities. Ultrastructural studies of CA3 cells performed in P60 (young adult) and > 9 months (mature) tissue showed that organelle defects are persistent throughout life. Locomotor activity and fear memory of young and mature adults were also abnormal: Dcx KO mice consistently performed less well than WT littermates, with defects becoming more severe with age. Thus, we show that disruption of a neurodevelopmentally-regulated gene can lead to permanent organelle anomalies contributing to abnormal adult behavior.


Subject(s)
Doublecortin Protein/genetics , Neuropeptides , Animals , Doublecortin Domain Proteins , Golgi Apparatus , Hippocampus/metabolism , Mice , Mice, Knockout , Microtubule-Associated Proteins/genetics , Microtubule-Associated Proteins/metabolism , Mitochondria/metabolism , Mutation , Neuropeptides/genetics , Neuropeptides/metabolism , Pyramidal Cells/metabolism
2.
Neuromuscul Disord ; 25(6): 461-73, 2015 Jun.
Article in English | MEDLINE | ID: mdl-25817838

ABSTRACT

Mutations in the microtubule-associated protein doublecortin (DCX) cause type I (X-linked or XLIS) lissencephaly in hemizygous males and subcortical band heterotopia (SBH) in females, with defects in neuron migration during development affecting cortical lamination. We found that besides its well-established expression in migrating neurons of the brain, doublecortin (Dcx in mice) is also expressed in motor neurons and skeletal muscle in embryonic neuromuscular junctions (NMJs), raising the possibility of a role in synaptogenesis. Studies with whole-mount preparations of embryonic mouse diaphragm revealed that loss of Dcx leads to abnormal presynaptic arborization and a significantly increased incidence of short axonal extensions beyond innervated acetylcholine receptor (AChR) clusters in the developing NMJ. This phenotype, albeit relatively mild, suggests that Dcx contributes to a stop/stabilizing signal at the synapse, which normally limits further axonal growth following establishment of synaptic contact with the postsynaptic element. Importantly, we also identified abnormal and denervated NMJs in a muscle biopsy from a 16-year-old female patient with SBH, showing both profound presynaptic and postsynaptic morphological defects. Overall, these combined results point to a critical role of doublecortin in the formation of the NMJ.


Subject(s)
Classical Lissencephalies and Subcortical Band Heterotopias/pathology , Microtubule-Associated Proteins/metabolism , Neuromuscular Junction/embryology , Neuromuscular Junction/metabolism , Neuropeptides/metabolism , Adolescent , Animals , Axons/metabolism , Brain/embryology , Brain/pathology , Cell Line , Classical Lissencephalies and Subcortical Band Heterotopias/genetics , Doublecortin Domain Proteins , Doublecortin Protein , Female , Humans , Male , Mice , Mice, Knockout , Microtubule-Associated Proteins/genetics , Motor Neurons/metabolism , Motor Neurons/pathology , Muscle, Skeletal/pathology , Neuromuscular Junction/genetics , Neuromuscular Junction/pathology , Neurons/metabolism , Neurons/pathology , Neuropeptides/genetics , Receptors, Cholinergic/metabolism
3.
Neuroscience ; 165(4): 1074-86, 2010 Feb 17.
Article in English | MEDLINE | ID: mdl-19931598

ABSTRACT

Previous findings suggest that neuroadaptations downstream of D-1 dopamine (DA) receptor stimulation in nucleus accumbens (NAc) are involved in the enhancement of drug reward by chronic food restriction (FR). Given the high co-expression of D-1 and GluR1 AMPA receptors in NAc, and the regulation of GluR1 channel conductance and trafficking by D-1-linked intracellular signaling cascades, the present study examined effects of the D-1 agonist, SKF-82958, on NAc GluR1 phosphorylation, intracranial electrical self-stimulation reward (ICSS), and reversibility of reward effects by a polyamine GluR1 antagonist, 1-NA-spermine, in ad libitum fed (AL) and FR rats. Systemically administered SKF-82958, or brief ingestion of a 10% sucrose solution, increased NAc GluR1 phosphorylation on Ser845, but not Ser831, with a greater effect in FR than AL rats. Microinjection of SKF-82958 in NAc shell produced a reward-potentiating effect that was greater in FR than AL rats, and was reversed by co-injection of 1-NA-spermine. GluR1 abundance in whole cell and synaptosomal fractions of NAc did not differ between feeding groups, and microinjection of AMPA, while affecting ICSS, did not exert greater effects in FR than AL rats. These results suggest a role of NAc GluR1 in the reward-potentiating effect of D-1 DA receptor stimulation and its enhancement by FR. Moreover, GluR1 involvement appears to occur downstream of D-1 DA receptor stimulation rather than reflecting a basal increase in GluR1 expression or function. Based on evidence that phosphorylation of GluR1 on Ser845 primes synaptic strengthening, the present results may reflect a mechanism via which FR normally facilitates reward-related learning to re-align instrumental behavior with environmental contingencies under the pressure of negative energy balance.


Subject(s)
Food Deprivation/physiology , Nucleus Accumbens/drug effects , Nucleus Accumbens/physiology , Receptors, AMPA/metabolism , Receptors, Dopamine D1/metabolism , Reward , Animals , Benzazepines/pharmacology , Dietary Sucrose , Dopamine Agonists/pharmacology , Eating/physiology , Electric Stimulation , Excitatory Amino Acid Antagonists/pharmacology , Male , Neurons/drug effects , Neurons/physiology , Phosphorylation/drug effects , Rats , Rats, Sprague-Dawley , Receptors, AMPA/antagonists & inhibitors , Receptors, Dopamine D1/agonists , Self Administration , Spermine/pharmacology , Synaptosomes/drug effects , Synaptosomes/physiology , alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid/metabolism
4.
Biochemistry ; 37(16): 5730-7, 1998 Apr 21.
Article in English | MEDLINE | ID: mdl-9548959

ABSTRACT

Mutational studies in conjunction with ligand binding assays were used to examine the basis of alpha1-adrenergic receptor subtype selectivity for a series of 4-piperidyloxazole antagonists. A set of chimeric alpha 1A receptors were created by systematically substituting individual transmembrane domains from alpha 1D adrenergic receptors. The oxazole antagonists exhibited significant reductions in affinity against the receptor construct alpha 1A/D(TM2), and moderate reductions in affinity versus constructs alpha 1A/D(TM5), alpha 1A/B(TM5), and alpha 1A/D(TM6). Antagonist affinities for these chimeras exceeded those found for wild type alpha 1D and alpha 1B. Site-directed mutagenesis methods were then used to explore the role that individual residues in TM2 and TM5 play in ligand binding affinity and selectivity. These studies revealed that mutations at position 86 in the second transmembrane domain and position 185 in the fifth transmembrane domain of the alpha 1A receptor have a major impact on receptor subtype selectivity.


Subject(s)
Adrenergic alpha-1 Receptor Antagonists , Adrenergic alpha-Antagonists/pharmacology , Oxazoles/pharmacology , Piperidines/pharmacology , Adrenergic alpha-Antagonists/chemistry , Amino Acid Sequence , Animals , COS Cells , Cell Membrane/metabolism , Ligands , Molecular Sequence Data , Mutagenesis, Site-Directed , Oxazoles/chemistry , Piperidines/chemistry , Receptors, Adrenergic, alpha-1/chemistry , Receptors, Adrenergic, alpha-1/genetics , Recombinant Fusion Proteins/antagonists & inhibitors , Recombinant Fusion Proteins/chemistry
SELECTION OF CITATIONS
SEARCH DETAIL
...